Not Medicare Enrolled

Dr. Dhiren Patel, DO

Addiction Medicine (Psychiatry & Neurology) Physician · Dallas, TX
1475 PRUDENTIAL DR, Dallas, TX 75235
2145224640
Registered in NPPES since 2006
NPI: 1528078466 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Dhiren Patel is an addiction medicine physician in Dallas, TX, with 20 years of NPI registration.

Between the years covered by Open Payments, Dr. Patel received a total of $25,146 from 49 pharmaceutical and/or device companies across 1008 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration $25,146 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$25,146
Total received (2018-2024)
Avg $3,592/year across 7 years
Top 21% in TX for addiction medicine (psychiatry & neurology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
1,008
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,132
2023
$3,089
2022
$1,612
2021
$2,086
2020
$1,295
2019
$5,499
2018
$7,433

Payments by company (2024)

Janssen Pharmaceuticals, Inc
$556
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$344
Takeda Pharmaceuticals U.S.A., Inc.
$333
Otsuka America Pharmaceutical, Inc.
$327
Corium, LLC
$309
Lundbeck LLC
$294
ABBVIE INC.
$236
Almatica Pharma LLC
$228
Tris Pharma Inc
$210
Indivior Inc.
$197
Teva Pharmaceuticals USA, Inc.
$154
Braeburn Inc.
$152
Axsome Therapeutics, Inc.
$134
Supernus Pharmaceuticals, Inc.
$124
Bausch Health US, LLC
$104
Alkermes, Inc.
$77
Orexo US, Inc.
$52
IDORSIA PHARMACEUTICALS US INC
$47
IRONSHORE PHARMACEUTICALS INC.
$40
Neos Therapeutics, LP
$37
Tempus AI, Inc
$34
Vertical Pharmaceuticals, LLC
$28
Noven Therapeutics, LLC
$27
Vanda Pharmaceuticals Inc.
$25
Neurocrine Biosciences, Inc.
$23
OWP Pharmaceuticals, Inc.
$23
E.R. Squibb & Sons, L.L.C.
$16
Top 3 companies account for 29.8% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$4,346
US WorldMeds, LLC
$4,019
Otsuka America Pharmaceutical, Inc.
$2,674
Neuronetics, Inc.
$1,883
Takeda Pharmaceuticals U.S.A., Inc.
$1,305
Lundbeck LLC
$1,193
Indivior Inc.
$909
Tris Pharma Inc
$882
Sunovion Pharmaceuticals Inc.
$801
ABBVIE INC.
$639
Almatica Pharma LLC
$436
Corium, LLC
$401
Teva Pharmaceuticals USA, Inc.
$372
Ironshore Pharmaceuticals Inc.
$366
Bausch Health US, LLC
$361
AbbVie Inc.
$356
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$344
ITI, Inc.
$342
Supernus Pharmaceuticals, Inc.
$321
Orexo US, Inc.
$273
Allergan Inc.
$273
Neos Therapeutics, LP
$224
Neurocrine Biosciences, Inc.
$223
Shire North American Group Inc
$223
IDORSIA PHARMACEUTICALS US INC
$213
Eisai Inc.
$188
Alkermes, Inc.
$178
Braeburn Inc.
$172
Axsome Therapeutics, Inc.
$159
Noven Therapeutics, LLC
$139
Vanda Pharmaceuticals Inc.
$129
Allergan, Inc.
$117
Avanir Pharmaceuticals, Inc.
$103
Vertical Pharmaceuticals, LLC
$98
ARBOR PHARMACEUTICALS, INC.
$64
OWP Pharmaceuticals, Inc.
$47
Merck Sharp & Dohme LLC
$44
IRONSHORE PHARMACEUTICALS INC.
$40
Pear Therapeutics (US), Inc.
$40
JAZZ PHARMACEUTICALS INC.
$38
Adlon Therapeutics L.P.
$35
Tempus AI, Inc
$34
EISAI INC.
$34
Merck Sharp & Dohme Corporation
$22
Hikma Pharmaceuticals USA
$21
Biogen, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$16
USWM, LLC
$14
Amgen Inc.
$14
Top 3 companies account for 43.9% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ABILIFY MYCITE · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Aimovig · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BRIXADI · CAPLYTA · COBENFY · Dayvigo · Dyanavel XR · Evekeo · FANAPT · Fanapt · Fycompa · GRALISE · HETLIOZ · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · Kloxxado · LATUDA · LOREEV XR · Lamotrigine Starter Kit · Lucemyra · Lucemyra/Lofexidine · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY · NUEDEXTA · QELBREE · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · RELEXXII · REXULTI · Relexxii · SPINRAZA · SPRAVATO · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · Secuado · Subvenite · TRINTELLIX · Trintellix · UBRELVY · UZEDY · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · WELLBUTRIN · WELLBUTRIN XL · Zubsolv · reSET-O
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an addiction medicine physician in Dallas?
Compare addiction medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse addiction medicine physicians nearby

Geographic Context

Addiction medicine physicians in nearby ZIP areas
7
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
PARKLAND HEALTH & HOSPITAL SYSTEM
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Patel is an addiction medicine physician, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $25,146 from 49 companies across 1,008 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Addiction Medicine Physicians in Dallas
Browse addiction medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in TX
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in TX
Which TX addiction medicine physicians receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
US WorldMeds, LLC Payments to Doctors
See all physicians who received payments from US WorldMeds, LLC.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →